✦ LIBER ✦

Non-myeloablative stem cell transplantation for induction of host-versus-graft tolerance for adoptive immunotherapy of malignant and nonmalignant diseases and towards transplantation of organ allografts

✍ Scribed by S Slavin

Book ID: 117232814
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 58 KB
Volume: 34
Category: Article
ISSN: 0041-1345
DOI: 10.1016/s0041-1345(02)03625-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Non-myeloablative stem cell transplantat

Non-myeloablative stem cell transplantation (Nst) For the treatment of malignant and non-malignant diseases

✍ S. Slavin; A. Nagler; M. Shapira; S. Panigrahi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 14 KB

Post transplant persistence of host cell

Post transplant persistence of host cells augments the intensity of acute graft-versus-host disease and level of donor chimerism, an explanation for graft-versus-host disease and rapid displacement of host cells seen following non-myeloablative stem cell transplantation?

✍ Hirshfeld, E; Weiss, L; Kasir, J; Zeira, M; Slavin, S; Shapira, M Y 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 138 KB

Low-dose alemtuzumab (Campath®) in myelo

Low-dose alemtuzumab (Campath®) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics

✍ Khouri, I F; Albitar, M; Saliba, R M; Ippoliti, C; Ma, Y C; Keating, M J; Champl 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 123 KB

Kinetics of dendritic cells reconstituti

Kinetics of dendritic cells reconstitution and costimulatory molecules expression after myeloablative allogeneic haematopoetic stem cell transplantation: Implications for the development of acute graft-versus host disease

✍ Rudolf Horváth; Vít Budinský; Jana Kayserová; Tomáš Kalina; Renata Formánková; J 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 552 KB

Mesenchymal Stem Cell Therapy || Mesench

Mesenchymal Stem Cell Therapy || Mesenchymal Stem Cells for Treatment and Prevention of Graft-Versus-Host Disease and Graft Failure After Hematopoietic Stem Cell Transplantation and Future Challenges

✍ Chase, Lucas G.; Vemuri, Mohan C. 📂 Article 📅 2012 🏛 Humana Press 🌐 English ⚖ 417 KB

Over the past decade, significant efforts have been made to develop stem cell-based therapies for difficult to treat diseases. Multipotent mesenchymal stromal cells, also referred to as mesenchymal stem cells (MSCs), appear to hold great promise in regards to a regenerative cell-based therapy for th

Use of nonmyeloablative preparative regi

Use of nonmyeloablative preparative regimens for allogeneic blood stem cell transplantation: Induction of graft-vs.-malignancy as treatment for malignant diseases

✍ Richard Champlin; Issa Khouri; Sergio Giralt 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 36 KB